The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg
Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers
โ Scribed by B. Hamon-Vilcot; S. Chaufour; C. Deschamps; M. Canal; I. Zieleniuk; P. Ahtoy; P. Chretien; P. Rosenzweig; A. Nasr; F. Piette
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 160 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Sumatriptan is classified as a vascular 5HT 1 receptor agonist and is effective in the acute treatment of migraine and cluster headache. Sumatriptan is available as an injection for subcutaneous administration and as a tablet for oral administration. The pharmacokinetics of sumatriptan differ depend
## Abstract The pharmacokinetics of reboxetine, a new antidepressant agent, were found to be close to linear in a crossover study comparing administration of single 2, 3, 4 and 5 mg capsule doses in 15 healthy male volunteers, and in the same study the capsules were bioequivalent to the proposed th
The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.